Project Grant HT94252510389
Award Date
9/1/25
Completion Date
8/31/26
Dollars Obligated
$176K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The Defense Health Agency has awarded a $1,387,727 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Sloan-Kettering Institute for Cancer Research. The grant, titled "Integrated Immunomodulatory Analysis of LAG3 Inhibition in Renal Cell Carcinoma", will fund research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate innovative approaches to cancer diagnosis,...
The Defense Health Agency awarded a $923,805 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research in New York. The grant supports a 3-year research project titled "Systematic Functional Dissection of Cancer Cell States in Lung Tumors" starting September 1, 2025. The grant aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $533,308 project grant to the Sloan-Kettering Institute for Cancer Research in New York, NY under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 1, 2025 to August 31, 2029, will support integrated immunomodulatory analysis of LAG3 inhibition in renal cell carcinoma. The Sloan-Kettering Institute, a leading nonprofit cancer research institution, will conduct advanced biomedical research aimed at...
The Defense Health Agency awarded a $1,108,654 Project Grant to the Sloan-Kettering Institute for Cancer Research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 30, 2025, will fund research to accelerate global research for relapsed or refractory extracranial malignant germ cell tumors. The Sloan-Kettering Institute, a leading nonprofit cancer research institution, will leverage its extensive capabilities in cancer biology, genomics,...
The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,194,586 project grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The grant, awarded on September 30, 2023, will support a 3-year research project titled "COEVOLUTION OF METABOLISM AND IMMUNE MICROENVIRONMENT AS A DRIVER OF THERAPEUTIC RESPONSE AND METASTASIS IN CCRCC". Through this grant, the Sloan-Kettering Institute...
This federal Project Grant award of $708,000.00 provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The research project is focused on investigating the "Prevalence and Biologic Impact of FGFR3 Genomic Alterations in Bladder Cancer". The 2-year award period runs from September 15, 2023 to...
The Defense Health Agency awarded a $3,705,142 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Sloan-Kettering Institute for Cancer Research. The grant supports a Phase 2 study of sacituzumab govitecan-hziyin in patients with previously treated mesotheliomas. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful medical research. The study will be conducted at the...
This federal Project Grant award for $704,000.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Sloan-Kettering Institute for Cancer Research in New York, NY. The research aims to investigate the role of the NF-I/A transcription factor in regulating fatty acid metabolism in kidney cancer. This multi-year project will run from September 1, 2024 to August 31, 2028. As the prime grantee, the Sloan-Kettering...
The Defense Health Agency awarded a $352,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Sloan-Kettering Institute for Cancer Research. The grant, titled "AUGMENTING IN VIVO EFFICACY OF A NOVEL LANOSTEROL SYNTHASE INHIBITOR IN GLIOBLASTOMA", will support advanced biomedical research to investigate innovative treatments for glioblastoma, a type of brain cancer. The research, spanning from September 2025 to August 2027, aims to...